Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors

Descripción del Articulo

Objective: To describe the characteristics of clinically non-functioning hypothalamic-pituitary tumors (THCNF). Material and methods: Descriptive, cross-sectional, retrospective study of 67 THCNF stories. from patients who attended the author's private practice, collected from January 2 to Marc...

Descripción completa

Detalles Bibliográficos
Autor: Garmendia-Lorena, Fausto
Formato: artículo
Fecha de Publicación:2024
Institución:Fundación Instituto Hipólito Unanue
Repositorio:Diagnóstico
Lenguaje:español
OAI Identifier:oai:revistadiagnostico.fihu.org.pe:article/515
Enlace del recurso:https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/515
Nivel de acceso:acceso abierto
Materia:Hipotálamo
hipófisis
tumores
no funcionantes
Hypothalamus
pituitary gland
tumors
non-functioning
id REVFIHU_97cf7d021f0968d12cfca6ab64eee7ed
oai_identifier_str oai:revistadiagnostico.fihu.org.pe:article/515
network_acronym_str REVFIHU
network_name_str Diagnóstico
repository_id_str
dc.title.none.fl_str_mv Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors
Diagnóstico, evolución y tratamiento de los tumores hipotálamo-hipofisarios clínicamente no funcionantes
title Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors
spellingShingle Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors
Garmendia-Lorena, Fausto
Hipotálamo
hipófisis
tumores
no funcionantes
Hypothalamus
pituitary gland
tumors
non-functioning
title_short Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors
title_full Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors
title_fullStr Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors
title_full_unstemmed Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors
title_sort Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumors
dc.creator.none.fl_str_mv Garmendia-Lorena, Fausto
author Garmendia-Lorena, Fausto
author_facet Garmendia-Lorena, Fausto
author_role author
dc.subject.none.fl_str_mv Hipotálamo
hipófisis
tumores
no funcionantes
Hypothalamus
pituitary gland
tumors
non-functioning
topic Hipotálamo
hipófisis
tumores
no funcionantes
Hypothalamus
pituitary gland
tumors
non-functioning
description Objective: To describe the characteristics of clinically non-functioning hypothalamic-pituitary tumors (THCNF). Material and methods: Descriptive, cross-sectional, retrospective study of 67 THCNF stories. from patients who attended the author's private practice, collected from January 2 to March 31, 2023 with manifestations of expansion of the hypothalamus-pituitary region. Information is given on age, weight, height, BMI, blood pressure, concentrations of prolactin (PRL), thyrotrophic hormone (TSH), luteotrophic hormone (LH), follicle-stimulating hormone (FSH), somatotropin (STH), thyroxine (T4), triiodo-thyronine (T3), cortisol (F), testosterone (T) in men, estradiol (E2) in women, glucose (G). Stimulatory tests with TRH, GnRH, insulin hypoglycemia, x-rays, ocular campimetry and treatment. Results: 53.7% women, 42.2± 15.5 years old, weight 71.1kg, height 1.63m, BMI 26.1, BP 130/75 mmHg, PRL14.9±12.3 ng/ml, STH 1.00 ±1.51 ng/ml, TSH 4.06±3.65 mIU/L, LH 5.69±5.28 IU/L, T4 6.86±2.68 ug/dl, T3 92.0±20.8 ng/dl, F 10.4 ±7.52 ug/dl, T 2.68±3.25 ng/dL, E2 28.3±9.07 pg/ml. TRH test: 6.56-14.8-14.8 mIU/L TSH. GnRH test: 4.0, 6.09, 6.11, 8.32, 6.87 IU/L LH. Insulin hypoglycemia: 0.95, 0.94, 2.24, 1.23, 1.4 ng/ml STH; 6.82, 9.64, 12.3, 11.6, 9.9 ug/dL cortisol. Blood glucose 86.6±7.08, 39.5±11.0, 63.3±10.9, 74.0±12.7, 77.0±12.0. All showed an increase in the sella turcica. Except for 3 who had normal vision, the rest presented altered vision from bitemporal hemianopia to blindness. The majority underwent transsphenoidal hypophysectomy, some received additional radiotherapy. Conclusions: THCNF had normal basal hormonal concentrations and limited responses to stimulatory tests. 
publishDate 2024
dc.date.none.fl_str_mv 2024-05-24
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/515
10.33734/diagnostico.v63i2.515
url https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/515
identifier_str_mv 10.33734/diagnostico.v63i2.515
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/515/492
dc.rights.none.fl_str_mv Derechos de autor 2024 Fausto Garmendia-Lorena
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2024 Fausto Garmendia-Lorena
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Fundación Instituto Hipólito Unanue
publisher.none.fl_str_mv Fundación Instituto Hipólito Unanue
dc.source.none.fl_str_mv Diagnóstico; Vol. 63 No. 2 (2024); e515
Diagnostico; Vol. 63 Núm. 2 (2024); e515
1018-2888
2709-7951
10.33734/diagnostico.v63i2
reponame:Diagnóstico
instname:Fundación Instituto Hipólito Unanue
instacron:FIHU
instname_str Fundación Instituto Hipólito Unanue
instacron_str FIHU
institution FIHU
reponame_str Diagnóstico
collection Diagnóstico
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1842087236504387584
spelling Diagnosis, evolution and treatment of hypothalamic-pituitary clinically non functioning tumorsDiagnóstico, evolución y tratamiento de los tumores hipotálamo-hipofisarios clínicamente no funcionantesGarmendia-Lorena, FaustoHipotálamohipófisistumoresno funcionantesHypothalamuspituitary glandtumorsnon-functioningObjective: To describe the characteristics of clinically non-functioning hypothalamic-pituitary tumors (THCNF). Material and methods: Descriptive, cross-sectional, retrospective study of 67 THCNF stories. from patients who attended the author's private practice, collected from January 2 to March 31, 2023 with manifestations of expansion of the hypothalamus-pituitary region. Information is given on age, weight, height, BMI, blood pressure, concentrations of prolactin (PRL), thyrotrophic hormone (TSH), luteotrophic hormone (LH), follicle-stimulating hormone (FSH), somatotropin (STH), thyroxine (T4), triiodo-thyronine (T3), cortisol (F), testosterone (T) in men, estradiol (E2) in women, glucose (G). Stimulatory tests with TRH, GnRH, insulin hypoglycemia, x-rays, ocular campimetry and treatment. Results: 53.7% women, 42.2± 15.5 years old, weight 71.1kg, height 1.63m, BMI 26.1, BP 130/75 mmHg, PRL14.9±12.3 ng/ml, STH 1.00 ±1.51 ng/ml, TSH 4.06±3.65 mIU/L, LH 5.69±5.28 IU/L, T4 6.86±2.68 ug/dl, T3 92.0±20.8 ng/dl, F 10.4 ±7.52 ug/dl, T 2.68±3.25 ng/dL, E2 28.3±9.07 pg/ml. TRH test: 6.56-14.8-14.8 mIU/L TSH. GnRH test: 4.0, 6.09, 6.11, 8.32, 6.87 IU/L LH. Insulin hypoglycemia: 0.95, 0.94, 2.24, 1.23, 1.4 ng/ml STH; 6.82, 9.64, 12.3, 11.6, 9.9 ug/dL cortisol. Blood glucose 86.6±7.08, 39.5±11.0, 63.3±10.9, 74.0±12.7, 77.0±12.0. All showed an increase in the sella turcica. Except for 3 who had normal vision, the rest presented altered vision from bitemporal hemianopia to blindness. The majority underwent transsphenoidal hypophysectomy, some received additional radiotherapy. Conclusions: THCNF had normal basal hormonal concentrations and limited responses to stimulatory tests. Objetivo: Describir las características de los tumores hipotálamo-hipofisarios clinicamente no funcionantes (THCNF). Material y métodos: Estudio descriptivo, transversal, retrospectivo de 67 historias de THCNF de pacientes que asistieron a la práctica privada del autor, recolectadas del 02 de enero al 31 de marzo del año 2023 con manifestaciones de expansión de la región hipotálamo hipofisaria. Se informa sobre la edad, peso, talla, IMC, presión arterial, concentraciones de prolactina (PRL), hormona tirotrófica (TSH), luteotrófica (LH), folículo-estimulante (FSH), somatotropina (STH), tiroxina (T4), triiodo-tironina (T3), cortisol (F), testosterona (T) en varones, estradiol (E2) en mujeres, glucosa (G). Pruebas estimulatorias con TRH, GnRH, hipoglicemia insulínica, radiografías, campimetrías oculares y tratamiento. Resultados: 53,7 % mujeres, 42,2± 15,5 años, peso 71,1kg, talla 1.63m, IMC 26,1, PA 130/75 mmHg, PRL14,9±12,3 ng/ml, STH 1,00±1,51 ng/ml, TSH 4,06±3,65 mUI/L, LH 5,69±5,28 UI/L, T4 6.86±2,68 ug/dl, T3 92,0±20,8 ng/dl , F 10,4 ±7,52 ug/dl, T 2,68±3,25 ng/dL, E2 28,3±9,07 pg/ml. Prueba TRH: 6,56-14,8-14,8 mUI/L de TSH. Prueba GnRH: 4,0, 6,09, 6,11, 8,32, 6,87 UI/L de LH. Hipoglicemia insulínica: 0,95, 0,94, 2,24, 1,23, 1,4 ng/ml de STH; 6,82, 9,64, 12,3, 11,6, 9,9 ug/dL de cortisol. Glicemia 86,6±7,08, 39,5±11,0, 63,3±10,9, 74,0±12,7, 77,0±12,0. Todos mostraron incremento de la silla turca. Excepto 3 que tuvieron visión normal, el resto presentó alteración de la visión desde hemianopsia bitemporal hasta ceguera La mayoría fue sometida a hipofisectomía transesfenoidal, algunos recibieron radioterapia adicional. Conclusiones: Los THCNF tuvieron concentraciones hormonales basales normales y respuestas limitadas a las pruebas estimulatorias.Fundación Instituto Hipólito Unanue2024-05-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/51510.33734/diagnostico.v63i2.515Diagnóstico; Vol. 63 No. 2 (2024); e515Diagnostico; Vol. 63 Núm. 2 (2024); e5151018-28882709-795110.33734/diagnostico.v63i2reponame:Diagnósticoinstname:Fundación Instituto Hipólito Unanueinstacron:FIHUspahttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/515/492Derechos de autor 2024 Fausto Garmendia-Lorenahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:revistadiagnostico.fihu.org.pe:article/5152024-08-23T01:20:24Z
score 13.10263
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).